Faralimomab
Appearance
From Wikipedia, the free encyclopedia
This is an old revision of this page, as edited by CheMoBot (talk | contribs) at 06:37, 8 September 2016 (Updating {{infobox_drug}} (changes to verified fields - updated 'ChemSpiderID_Ref') per Chem/infobox_drug validation (report errors or bugs)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Mouse |
Target | Interferon receptor |
Clinical data | |
ATC code |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
![]() ![]() |
Faralimomab is a mouse monoclonal antibody and an immunomodulator.[1]
References
Intracellular (initiation) |
| ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Intracellular (reception) |
| ||||||||||||||
Extracellular |
| ||||||||||||||
Unsorted |
|
Chemokine |
| ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CSF |
| ||||||||||||
Interferon |
| ||||||||||||
Interleukin |
| ||||||||||||
TGFβ |
| ||||||||||||
TNF |
| ||||||||||||
Others |
|
![]() | This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it. |
![]() | This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it. |
Hidden categories:
- Articles with changed CASNo identifier
- Chemicals that do not have a ChemSpider ID assigned
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Drugs that are a monoclonal antibody
- All stub articles